Ethics of Biotechnology
From SI410
Revision as of 22:31, 27 January 2022 by
Reelj
(
Talk
|
contribs
)
(
→
Background/History
)
(
diff
)
← Older revision
|
Latest revision
(
diff
) |
Newer revision →
(
diff
)
Jump to:
navigation
,
search
Contents
1
Background
2
Customer-Facing Genetic Testing
2.1
Theranos Scandal
2.2
23andMe
2.2.1
2013 FDA Ban
2.2.2
Privacy Concerns
3
Stem Cell Controversy
3.1
History
3.2
Emergence of Embryonic Stem Cells
3.3
Points of Debate
4
Genetic Engineering
4.1
Gene Editing in Embryos
4.1.1
"Designer Babies"
4.1.2
He Jiankui Controversy
5
Privacy Concerns
Background
Customer-Facing Genetic Testing
Theranos Scandal
23andMe
2013 FDA Ban
Privacy Concerns
Stem Cell Controversy
History
Emergence of Embryonic Stem Cells
Points of Debate
Genetic Engineering
Gene Editing in Embryos
"Designer Babies"
He Jiankui Controversy
Privacy Concerns
Navigation menu
Personal tools
Log in
Namespaces
Page
Discussion
Variants
Views
Read
View source
View history
More
Search
Navigation
Main page
Recent changes
Random page
Help
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information